NuCana
Patents, Design & Utilities
Last updated:
List of all NuCana patents 38 in total
| Status | Patent |
|---|---|
Grant | Utility: Floxuridine synthesis Filling date: 6 Sep 2025 Issue date: 16 Aug 2022 |
Grant | Utility: Synthesis of phosphate derivatives Filling date: 6 Sep 2025 Issue date: 16 Aug 2022 |
Grant | Utility: Cancer treatments Filling date: 6 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: Crystalline form of gemcitabine Filling date: 6 Sep 2025 Issue date: 5 Jul 2022 |
Grant | Utility: 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds Filling date: 6 Sep 2025 Issue date: 7 Jun 2022 |
Application | Utility: FORMULATION COMPRISING A GEMCITABINE-PRODRUG Filling date: 6 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: PROCESS FOR PREPARING NUCLEOSIDE PRODRUGS Filling date: 6 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS Filling date: 6 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: SALT OF TRIPHOSPHATE PHOSPHORAMIDATES OF NUCLEOTIDES AS ANTICANCER COMPOUNDS Filling date: 6 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: PHOSPHORAMIDATE DERIVATIVES OF 5 - FLUORO - 2` - DEOXYURIDINE FOR USE IN THE TREATMENT OF CANCER Filling date: 6 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: CRYSTALLINE FORM OF GEMCITABINE Filling date: 6 Sep 2025 Issue date: 24 Jun 2021 |
Grant | Utility: Formulation comprising a gemcitabine-prodrug Filling date: 6 Sep 2025 Issue date: 22 Jun 2021 |
Grant | Utility: Process for preparing nucleoside prodrugs Filling date: 6 Sep 2025 Issue date: 22 Jun 2021 |
Application | Utility: SALTS OF DIPHOSPHATE PHOSPHORAMIDATE OF NUCLEOSIDES AS ANTICANCER COMPOUNDS Filling date: 6 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS Filling date: 6 Sep 2025 Issue date: 6 May 2021 |
Grant | Utility: Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer Filling date: 6 Sep 2025 Issue date: 4 May 2021 |
Application | Utility: CANCER TREATMENTS BASED ON GEMCITABINE PRODRUGS Filling date: 6 Sep 2025 Issue date: 8 Apr 2021 |
Grant | Utility: Phosphoramidate nucleoside derivatives as anticancer agents Filling date: 6 Sep 2025 Issue date: 2 Feb 2021 |
Application | Utility: DIASTEREOSELECTIVE SYNTHESIS OF PHOSPHATE DERIVATIVES Filling date: 6 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: FORMULATION COMPRISING A GEMCITABINE-PRODRUG Filling date: 6 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: Treatment Regimens Filling date: 6 Sep 2025 Issue date: 5 Nov 2020 |
Grant | Utility: Formulation comprising a gemcitabine-prodrug Filling date: 6 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Diastereoselective synthesis of phosphate derivatives Filling date: 6 Sep 2025 Issue date: 15 Sep 2020 |
Application | Utility: COMBINATION THERAPY FOR CANCER Filling date: 6 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: GEMCITABINE PRODRUGS Filling date: 6 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: FLOXURIDINE SYNTHESIS Filling date: 6 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: Combination Therapy Filling date: 6 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: 2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DERIVATIVES AS ANTI-CANCER COMPOUNDS Filling date: 6 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: SYNTHESIS OF 3'-DEOXYADENOSINE-5'-O-[PHENYL(BENZYLOXY-L-ALANINYL)]PHOSPHATE (NUC-7738) Filling date: 6 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: SYNTHESIS OF PHOSPHATE DERIVATIVES Filling date: 6 Sep 2025 Issue date: 11 Jun 2020 |
Grant | Utility: Methods of separating gemcitabine-phosphate diastereoisomers Filling date: 6 Sep 2025 Issue date: 2 Jun 2020 |
Grant | Utility: Combination therapy for cancer Filling date: 6 Sep 2025 Issue date: 26 May 2020 |
Grant | Utility: Gemcitabine prodrugs Filling date: 6 Sep 2025 Issue date: 26 May 2020 |
Grant | Utility: 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti- cancer compounds Filling date: 6 Sep 2025 Issue date: 25 Feb 2020 |
Application | Utility: PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS Filling date: 6 Sep 2025 Issue date: 12 Dec 2019 |
Application | Utility: ADENOSINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER Filling date: 6 Sep 2025 Issue date: 12 Dec 2019 |
Application | Utility: CANCER TREATMENTS Filling date: 6 Sep 2025 Issue date: 12 Dec 2019 |
Grant | Utility: Phosphoramidate compounds and methods of use Filling date: 6 Sep 2025 Issue date: 3 Sep 2019 |
Showing 1 to 38 of 38 patents.